Page 99 - MI-1-1
P. 99

Microbes & Immunity                                     Dynamics between phage, bacteria, and mammalian cells



               doi: 10.1073/pnas.1508355112                       of human cells by  Salmonella in vitro.  J Food Prot.
                                                                  2019;82(8):1336-1349.
            19.  Bichet MC, Chin WH, Richards W,  et al. Bacteriophage
               uptake by mammalian cell layers represents a potential sink      doi: 10.4315/0362-028x.Jfp-18-587
               that may impact phage therapy. iScience. 2021;24(4):102287.
                                                               30.  Peng F, Mi Z, Huang Y, et al. Characterization, sequencing
               doi: 10.1016/j.isci.2021.102287                    and comparative genomic analysis of vB_AbaM-IME-AB2,
                                                                  a novel lytic bacteriophage that infects multidrug-resistant
            20.  Nguyen S, Baker K, Padman BS,  et al. Bacteriophage
               transcytosis provides a mechanism to cross epithelial cell   Acinetobacter baumannii clinical isolates.  BMC Microbiol.
               layers. mBio. 2017;8(6):e01874-17.                 2014;14:181.
                                                                  doi: 10.1186/1471-2180-14-181
               doi: 10.1128/mBio.01874-17
                                                               31.  The Actinobacteriophage Database, Procedures and
            21.  Yan W, Banerjee P, Xu M, et al. Formulation strategies for
               bacteriophages to target intracellular bacterial pathogens.   Protocols  n.d. Available  from:  https://phagesdb.org/
               Adv Drug Deliv Rev. 2021;176:113864.               workflow [Last accessed on 2021 Sep 14].
                                                               32.  Adriaenssens EM, Lehman SM, Vandersteegen K,  et al.
               doi: 10.1016/j.addr.2021.113864
                                                                  CIM(®) monolithic anion-exchange chromatography
            22.  Alemayehu D, Casey PG, McAuliffe O, et al. Bacteriophages   as a useful alternative to CsCl gradient purification of
               φMR299-2  and  φNH-4  can  eliminate  Pseudomonas   bacteriophage particles. Virology. 2012;434(2):265-270.
               aeruginosa in the murine lung and on cystic fibrosis lung
               airway cells. mBio. 2012;3(2):e00029-12.           doi: 10.1016/j.virol.2012.09.018
                                                               33.  Carlson K. Appendix. Working with bacteriophages:
               doi: 10.1128/mBio.00029-12
                                                                  Common techniques and methodological approaches. In:
            23.  Debarbieux L, Leduc D, Maura D, et al. Bacteriophages can   Kutter E, Sulakvelidze A, editors.  Bacteriophages: Biology
               treat and prevent Pseudomonas aeruginosa lung infections. J   and Applications. United States: CRC Press; 2005. p. 437-494.
               Infect Dis. 2010;201(7):1096-1104.
                                                               34.  Humphries RM, Ambler J, Mitchell SL, et al. CLSI methods
               doi: 10.1086/651135                                development and standardization working group best
            24.  Møller-Olsen C, Ho SFS, Shukla RD, Feher T, Sagona AP.   practices for evaluation of antimicrobial susceptibility tests.
               Engineered K1F bacteriophages kill intracellular Escherichia   J Clin Microbiol. 2018;56(4):e01934-17.
               coli K1 in human epithelial cells. Sci Rep. 2018;8(1):17559.     doi: 10.1128/jcm.01934-17
               doi: 10.1038/s41598-018-35859-6                 35.  De  Plano  LM,  Franco  D,  Bonsignore  M,  et al.  Phage-
            25.  Núñez-Sánchez MA, Colom J, Walsh L, et al. Characterizing   phenotype imaging of myeloma  plasma cells by phage
               phage-host interactions in a simplified human intestinal   display. Appl Sci. 2021;11(17):7910.
               barrier model. Microorganisms. 2020;8(9):1374.  36.  Pirnay JP, Kutter E. Bacteriophages: It’s a medicine, Jim, but
               doi: 10.3390/microorganisms8091374                 not as we know it. Lancet Infect Dis. 2021;21(3):309-311.
            26.  Shan J, Ramachandran A, Thanki AM, Vukusic FBI, Barylski      doi: 10.1016/s1473-3099(20)30464-3
               J, Clokie MRJ. Bacteriophages are more virulent to bacteria   37.  Ross A, Ward S, Hyman P. More is better: Selecting for broad
               with human cells than they are in bacterial culture; insights   host range bacteriophages. Front Microbiol. 2016;7:1352.
               from HT-29 cells. Sci Rep. 2018;8(1):5091.
                                                                  doi: 10.3389/fmicb.2016.01352
               doi: 10.1038/s41598-018-23418-y
                                                               38.  Oechslin F. Resistance development to bacteriophages
            27.  Lee HY, Biswas D, Ahn J.  In-vitro adhesion and invasion   occurring  during  bacteriophage  therapy.  Viruses.
               properties  of  Salmonella  Typhimurium  competing  with   2018;10(7):351.
               bacteriophage in epithelial cells and chicken macrophages.
               Rev Bras Ciênc Avícola. 2015;17(4):427-432.        doi: 10.3390/v10070351
                                                               39.  Lee HW, Koh YM, Kim J,  et al. Capacity of multidrug-
            28.  Llanos-Chea A, Citorik RJ, Nickerson KP,  et al.
               Bacteriophage therapy testing against Shigella flexneri in a   resistant clinical isolates of Acinetobacter baumannii to form
               novel human intestinal organoid-derived infection model. J   biofilm and adhere to epithelial cell surfaces. Clin Microbiol
               Pediatr Gastroenterol Nutr. 2019;68(4):509-516.    Infect. 2008;14(1):49-54.
                                                                  doi: 10.1111/j.1469-0691.2007.01842.x
               doi: 10.1097/mpg.0000000000002203
                                                               40.  Sechi LA, Karadenizli A, Deriu A, et al. PER-1 type beta-
            29.  Moye ZD, Woolston J, Abbeele PVD, et al. A bacteriophage
               cocktail  eliminates  Salmonella  Typhimurium  from  the   lactamase production in Acinetobacter baumannii is related
               human  colonic  microbiome  while  preserving  cytokine   to cell adhesion. Med Sci Monit. 2004;10(6):Br180-Br184.
               signaling  and  preventing attachment  to  and  invasion   41.  Smani Y, McConnell MJ, Pachón J. Role of fibronectin in


            Volume 1 Issue 1 (2024)                         93                               doi: 10.36922/mi.3141
   94   95   96   97   98   99   100   101   102   103   104